Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Cost-efficient European adaptations of global health economic models

Experience with model adaptations in Austria, Belgium, France, Germany, Italy, Norway, Netherlands, Spain, Sweden, the UK

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

Extended reimbursement for next-generation sequencing (NGS) in Belgium

Molecular biology tests by next-generation sequencing (NGS) in oncology and hemato-oncology are temporarily reimbursed as a pilot under a specific agreement (Convention) with the National Institute for Health and Disability Insurance (INAMI-RIZIV) from 2019.

On July 1, 2023, the Convention was extended for one year. The lists with eligible clinical indications connected to specific biomarkers (separately for solid and hematological tumors) were updated as well.

See more information in French here and in Dutch here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.

Tags
Belgium
Reimbursement
Molecular diagnostics
Genetic tests

The latest related news

17
Dec 2024

Remote monitoring of patients with chronic heart failure will be reimbursed in Belgium

In December 2024, the National Institute for Health and Disability Insurance (INAMI/RIZIV) launched a new agreement (Convention) allowing reimbursement for remote monitoring of patients with chronic heart failure. It will come into force on January 1, 2025. New codes (pseudonomenclature) with fees for packages of care will be used for reimbursement. The packages include monitoring of clinical parameters by patients at home (e.g., blood pressure measurement or pulmonary artery pressure measured by an implanted sensor) and transmission of data via a health app to the remote monitoring team at the hospital.
Read more
04
Dec 2024

Recommendations about add-on reimbursement for medical devices in France in November 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the November 2024 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Two recommendations were published concerning the registration of new medical devices in the List of Reimbursable Products and Services (LPPR). Opinions were related to breast reconstruction and medical aids.
Read more
28
Nov 2024

The DRG tariffs for 2025 released in Denmark

On November 12, 2024, the Danish Health Data Authority published the DRG tariffs for 2025. In accordance with the released documentation, four new DRGs in the fields of radiology, dermatology, and the treatment of functional disorders will be introduced in 2025.
Read more
27
Nov 2024

New version of the CCAM Nomenclature published in France

In mid-November 2024, a new version of the classification of procedure codes (CCAM v.77), effective from January 1, 2025, was published. No new codes were introduced. The main changes concerned the tariff rules for procedures and their applications for doctors, as well as the modification of tariffs for 31 dental procedures.
Read more